Overall Study Question: What is the experience of patients with inflammatory bowel diseases (IBD) following a switch of infusion sites?
Specific Aims: We aim to evaluate the experience of patients with Inflammatory Bowel Diseases (IBD) following their transfer of care from one infusion site to another. Based on IBD patients’ experience, we will assess the need for intervention to improve transfer of infusion sites.
Study Period: Beginning in April 2022
Contact: Sirine Belaid